A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...
Cold and flu season means stuffy noses and plenty of sneezes. CNN’s Meg Tirrell examines why your body produces so much mucus and what the details say about your immune system. US President ...
Odours are first captured by special olfactory nerve cells inside your nose. These cells extend upwards from the roof of your nose towards the smell-processing centre of your brain, called the ...
Bhad Bhabie/Instagram Bhad Bhabie revealed she got a nose job amid her cancer treatment. On Tuesday, Jan. 21, the rapper, 21, shared the news via Instagram Stories, per reposts on X. The star ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
It may still work in nasal sprays. Topical decongestants ... This may help with sinus pain and stuffy nose from allergies, colds, or the flu. The FDA has approved its use for nasal congestion.
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...